国际皮肤性病学杂志    2005 31 (2): 110-112   ISSN: 2096-5540  CN: 32-1880/R   核因子-κB与炎症性皮肤病 宋艳丽, 文海泉, 肖嵘 中南大学湘雅二医院皮肤科 长沙 410011 收稿日期 2004-06-15  修回日期 null  网络版发布日期 null 参考文献  [1] Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res, 2004,119:139-173. [2] Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest, 2001, 107:241-246. [3] Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 1999, 18:6853-6866. [4] Anest V, Hanson JL, Cogswell PC, et al. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature, 2003, 423:659-663. [5] Bell S, Degitz K, Quirling M,et al. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal, 2003, 15:1-7. [6] Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med, 1999, 341:1817-1828. [7] Kaburagi Y, Shimada Y, Nagaoka T, et al. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res, 2001, 293:350-355. [8] Huber MA, Denk A, Peter RU,et al. The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J Biol Chem, 2002, 277:1268-1275. [9] Kraft S, Novak N, Katoh N, et al. Aggregation of the high-affinity IgE receptor Fc(epsilon)RI on human monocytes and dendritic cells induces NF-kappaB activation. J Invest Dermatol, 2002, 118:830-837. [10] Kraft S, Bieber T. Fc epsilon ri-mediated activation of transcription factors in antigen-presenting cells. Int Arch Allergy Immunol, 2001, 125:9-15. [11] Danning CL, Illei GG, Hitchon C, et al. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum, 2000, 43:1244-1256. [12] Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today, 1999, 20:40-46. [13] Wissink S, van Heerde EC, vand der Burg B, et al. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol, 1998, 12:355-363. [14] Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol, 2002, 2:725-734. [15] Khaled AR, Soares LS, Butfiloski EJ, et al. Inhibition of the p50 (NKkappaB1) subunit of NF-kappaB by phosphorothioate-modified antisense oligodeoxynucleotides reduces NF-kappaB expression and immunoglobulin synthesis in murine B cells. Clin Immunol Immunopathol, 1997, 83:254-263. [16] Becker H, Stengl G, Stein M, et al. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases. Clin Exp Immunol, 1995, 99:325-330. [17] Monici MC, Aguennouz M, Mazzeo A, et al. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology, 2003, 60:993-997. [18] Burgos P, Metz C, Bull P, et al. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus. J Rheumatol, 2000, 27:116-127. [19] Wong HK, Kammer GM, Dennis G, et al. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol, 1999, 163:1682-1689. [20] Abeyama K, Eng W, Jester JV, et al. A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest, 2000, 105:1751-1759. [21] Djavaheri-Mergny M, Gras MP, Mergny JL, et al. UV-A-induced decrease in nuclear factor-kappaB activity in human keratinocytes. Biochem J, 1999, 338:607-613. 通讯作者: